Jung L, Miske A, Indorf A, Nelson K, et al. A Retrospective Analysis of Metronomic Cyclophosphamide, Methotrexate, and Fluorouracil (CMF) Versus Docetaxel and Cyclophosphamide (TC) as Adjuvant Treatment in Early Stage, Hormone Receptor Positive, HER2 Negative Breast Cancer. Clin Breast Cancer 2021 Sep 22. pii: S1526-8209(21)00265.
PMID: 34753632